Clay Siegall, President & CEO, Director at Seagen, holds 666.06K shares in Seagen (Ticker: SGEN), holds ― shares in Synlogic (Ticker: SYBX), holds ― shares in Nurix Therapeutics (Ticker: NRIX).
Clay Siegall latest transaction was an Uninformative Sell of $272.02K.
What was Clay Siegall's most profitable transaction?
Clay Siegall’s most profitable transaction was an Informative Buy of IMNM stock on October 4, 2023. The return on the trade was 73.00%.
What is Clay Siegall's role in Seagen?
Clay Siegall's role in Seagen is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.